Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Adenocarcinoma.

Annals of surgery - 1 Aug 2022

Cabalag Carlos S, Yates Michael, Corrales Mariana Benitez, Yeh Paul, Wong Stephen Q, Zhang Bonnie Z, Fujihara Kenji M, Chong Lynn, Hii Michael W, Dawson Sarah-Jane, Phillips Wayne A, Duong Cuong P, Clemons Nicholas J

Abstract excerpt

OBJECTIVE: To explore the clinical utility of circulating tumor DNA (ctDNA) in esophageal adenocarcinoma (EAC) by developing a cost-effective and rapid technique utilising targeted amplicon sequencing. SUMMARY OF BACKGROUND DATA: Emerging evidence suggests that levels of ctDNA in the blood can be used to monitor treatment response and in the detection of disease recurrence in various cancer types. Current staging...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Circulating Tumor DNA

Share to Esophageal Neoplasms

Share to Mutation

Share to Neoplasm Recurrence, Local

Share to Positron Emission Tomography Computed Tomography

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 35737908
DOI: 10.1097/SLA.0000000000005177
PMCID: PMC9259043

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Adenocarcinoma.PMID 35737908Read ↗

A Review of Circulating Tumor DNA in the Diagnosis and Monitoring of Esophageal Cancer.Semantic proximity Read ↗

Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer.Semantic proximity Read ↗

Development of circulating tumour DNA analysis for gastrointestinal cancersSemantic proximity Read ↗

ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality.Semantic proximity Read ↗

Frequent tumor burden monitoring of esophageal squamous cell carcinoma with circulating tumor DNA using individually designed digital PCRSemantic proximity Read ↗

ctDNA as A Biomarker of Progression in Oesophageal AdenocarcinomaSemantic proximity Read ↗

Gene-specific ctDNA dynamics predict tumour burden and survival outcomes in ESCC: A prospective cohort study.Semantic proximity Read ↗

Detection of Circulating Tumor DNA in Plasma: A Potential Biomarker for Esophageal AdenocarcinomaSemantic proximity Read ↗

ctDNA as a biomarker of progression in oesophageal adenocarcinoma.Semantic proximity Read ↗

Molecular residual disease detection by serial tumour-informed circulating tumour DNA analysis in resectable oesophageal & gastroesophageal junctional adenocarcinoma: a prospective UK multi-centre studySemantic proximity Read ↗

Clinical value of preoperative circulating tumor DNA before surgery in patients with esophageal squamous cell carcinoma.Semantic proximity Read ↗

Genome-wide and panel-based cell-free DNA characterization of patients with resectable esophageal adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.